F. Marchesi, “Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study: Ceftolozane-Tazobatam for febrile neutropenia”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020065, Sep. 2020.